Literature DB >> 18625114

Ectopic fat and insulin resistance.

Angelika Lettner1, Michael Roden.   

Abstract

Ectopic fat is defined by the deposition of triglycerides within cells of non-adipose tissue that normally contain only small amounts of fat. Over the past decade, magnetic resonance spectroscopy has been used extensively for noninvasive quantification of intramyocellular, intrahepatocellular, and more recently myocardial and pancreatic lipids. In liver and muscle, triglyceride content usually correlates with whole-body and tissue-specific insulin sensitivity. However, fat mass and oxidative capacity influence this relationship, indicating that ectopic lipid content is not the only factor that explains insulin resistance. Ectopic lipids may rather serve as biomarkers of the balance between metabolic supply and demand in different states of insulin sensitivity. Consequently, ectopic lipid concentrations, particularly in the liver, decrease with lifestyle- or drug-induced improvement of insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625114     DOI: 10.1007/s11892-008-0032-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  50 in total

Review 1.  The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans.

Authors:  Martin Krssak; Michael Roden
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Authors:  Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

3.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

4.  Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans.

Authors:  O P Bachmann; D B Dahl; K Brechtel; J Machann; M Haap; T Maier; M Loviscach; M Stumvoll; C D Claussen; F Schick; H U Häring; S Jacob
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

5.  The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.

Authors:  Adam B Mayerson; Ripudaman S Hundal; Sylvie Dufour; Vincent Lebon; Douglas Befroy; Gary W Cline; Staffan Enocksson; Silvio E Inzucchi; Gerald I Shulman; Kitt F Petersen
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

6.  Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation.

Authors:  Gianluca Perseghin; Paola Scifo; Massimo Danna; Alberto Battezzati; Stefano Benedini; Elena Meneghini; Alessandro Del Maschio; Livio Luzi
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-09       Impact factor: 4.310

7.  Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

Authors:  Mirja Tiikkainen; Anna-Maija Häkkinen; Elena Korsheninnikova; Tuulikki Nyman; Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.

Authors:  Tetsuya Teranishi; Takeshi Ohara; Kengo Maeda; Masako Zenibayashi; Kunichi Kouyama; Yushi Hirota; Hideaki Kawamitsu; Masahiko Fujii; Kazuro Sugimura; Masato Kasuga
Journal:  Metabolism       Date:  2007-10       Impact factor: 8.694

9.  Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.

Authors:  Clinton R Bruce; Mitchell J Anderson; Andrew L Carey; David G Newman; Arend Bonen; Adamandia D Kriketos; Gregory J Cooney; John A Hawley
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Carbohydrate-induced manipulation of insulin sensitivity independently of intramyocellular lipids.

Authors:  Louise M Goff; Gary S Frost; Gavin Hamilton; E Louise Thomas; Waljit S Dhillo; Anne Dornhorst; Jimmy D Bell
Journal:  Br J Nutr       Date:  2003-03       Impact factor: 3.718

View more
  27 in total

Review 1.  Fat circadian biology.

Authors:  Jeffrey M Gimble; Z Elizabeth Floyd
Journal:  J Appl Physiol (1985)       Date:  2009-05-21

2.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

3.  Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.

Authors:  Jinghua Bie; Bin Zhao; Kathryn E Marqueen; Jing Wang; Barbara Szomju; Shobha Ghosh
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-06       Impact factor: 4.310

4.  Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation.

Authors:  David J Mancuso; Harold F Sims; Kui Yang; Michael A Kiebish; Xiong Su; Christopher M Jenkins; Shaoping Guan; Sung Ho Moon; Terri Pietka; Fatiha Nassir; Timothy Schappe; Kristin Moore; Xianlin Han; Nada A Abumrad; Richard W Gross
Journal:  J Biol Chem       Date:  2010-09-03       Impact factor: 5.157

5.  Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study.

Authors:  Hajime Yamazaki; Shinichi Tauchi; Miho Kimachi; Mitsuru Dohke; Nagisa Hanawa; Yoshihisa Kodama; Akio Katanuma; Yosuke Yamamoto; Shunichi Fukuhara; Shingo Fukuma
Journal:  J Gastroenterol       Date:  2017-12-13       Impact factor: 7.527

6.  RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.

Authors:  Xiao-Bing Cui; Jun-Na Luan; Shi-You Chen
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

7.  Imaging of Triglycerides in Tissues Using Nanospray Desorption Electrospray Ionization (Nano-DESI) Mass Spectrometry.

Authors:  Daisy Unsihuay; Jiamin Qiu; Sneha Swaroop; Konstantin O Nagornov; Anton N Kozhinov; Yury O Tsybin; Shihuan Kuang; Julia Laskin
Journal:  Int J Mass Spectrom       Date:  2019-11-27       Impact factor: 1.986

Review 8.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

9.  CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance.

Authors:  Chang-An Guo; Sophia Kogan; Shinya U Amano; Mengxi Wang; Sezin Dagdeviren; Randall H Friedline; Myriam Aouadi; Jason K Kim; Michael P Czech
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

10.  The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome.

Authors:  Frederick L Ruberg; Zhongjing Chen; Ning Hua; Sherman Bigornia; Zifang Guo; Kevin Hallock; Hernan Jara; Michael LaValley; Alkystis Phinikaridou; Ye Qiao; Jason Viereck; Caroline M Apovian; James A Hamilton
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.